Larsen BD - Search Results

1

Characterization of a novel peripheral pro-lipolytic mechanism in mice: role of VGF-derived peptide TLQP-21.

Possenti R, Muccioli G, Petrocchi P, Cero C, Cabassi A, Vulchanova L, Riedl MS, Manieri M, Frontini A, Giordano A, Cinti S, Govoni P, Graiani G, Quaini F, Ghè C, Bresciani E, Bulgarelli I, Torsello A, Locatelli V, Sanghez V, Larsen BD, Petersen JS, Palanza P, Parmigiani S, Moles A, Levi A, Bartolomucci A. Possenti R, et al. Among authors: larsen bd. Biochem J. 2012 Jan 1;441(1):511-22. doi: 10.1042/BJ20111165. Biochem J. 2012. PMID: 21880012

2

Glucagon-like peptide 1 receptor agonist ZP10A increases insulin mRNA expression and prevents diabetic progression in db/db mice.

Thorkildsen C, Neve S, Larsen BD, Meier E, Petersen JS. Thorkildsen C, et al. Among authors: larsen bd. J Pharmacol Exp Ther. 2003 Nov;307(2):490-6. doi: 10.1124/jpet.103.051987. Epub 2003 Sep 15. J Pharmacol Exp Ther. 2003. PMID: 12975499

3

Effects of the new antiarrhythmic peptide ZP123 on epicardial activation and repolarization pattern.

Dhein S, Larsen BD, Petersen JS, Mohr FW. Dhein S, et al. Among authors: larsen bd. Cell Commun Adhes. 2003 Jul-Dec;10(4-6):371-8. doi: 10.1080/cac.10.4-6.371.378. Cell Commun Adhes. 2003. PMID: 14681044 Free article.

4

Pharmacological characterization of the novel nociceptin/orphanin FQ receptor ligand, ZP120: in vitro and in vivo studies in mice.

Rizzi A, Rizzi D, Marzola G, Regoli D, Larsen BD, Petersen JS, Calo' G. Rizzi A, et al. Among authors: larsen bd. Br J Pharmacol. 2002 Oct;137(3):369-74. doi: 10.1038/sj.bjp.0704894. Br J Pharmacol. 2002. PMID: 12237257 Free PMC article.

5

Pharmacological characterization of the new stable antiarrhythmic peptide analog Ac-D-Tyr-D-Pro-D-Hyp-Gly-D-Ala-Gly-NH2 (ZP123): in vivo and in vitro studies.

Kjølbye AL, Knudsen CB, Jepsen T, Larsen BD, Petersen JS. Kjølbye AL, et al. Among authors: larsen bd. J Pharmacol Exp Ther. 2003 Sep;306(3):1191-9. doi: 10.1124/jpet.103.052258. Epub 2003 Jun 26. J Pharmacol Exp Ther. 2003. PMID: 12829724

6

Discovery of (2S,4R)-1-(2-aminoacetyl)-4-benzamidopyrrolidine-2-carboxylic acid hydrochloride (GAP-134)13, an orally active small molecule gap-junction modifier for the treatment of atrial fibrillation.

Butera JA, Larsen BD, Hennan JK, Kerns E, Di L, Alimardanov A, Swillo RE, Morgan GA, Liu K, Wang Q, Rossman EI, Unwalla R, McDonald L, Huselton C, Petersen JS. Butera JA, et al. Among authors: larsen bd. J Med Chem. 2009 Feb 26;52(4):908-11. doi: 10.1021/jm801558d. J Med Chem. 2009. PMID: 19175320

7

Caspase-Activated DNase localizes to cancer causing translocation breakpoints during cell differentiation.

Alsowaida D, Larsen BD, Hachmer S, Azimi M, Arezza E, Brunette S, Tur S, Palii CG, Albraidy B, Sorensen CS, Brand M, Dilworth FJ, Megeney LA. Alsowaida D, et al. Among authors: larsen bd. bioRxiv [Preprint]. 2024 Dec 20:2024.09.24.614809. doi: 10.1101/2024.09.24.614809. bioRxiv. 2024. PMID: 39386486 Free PMC article. Preprint.

8

Cold-induced expression of a truncated adenylyl cyclase 3 acts as rheostat to brown fat function.

Khani S, Topel H, Kardinal R, Tavanez AR, Josephrajan A, Larsen BDM, Gaudry MJ, Leyendecker P, Egedal NM, Güller AS, Stanic N, Ruppert PMM, Gaziano I, Hansmeier NR, Schmidt E, Klemm P, Vagliano LM, Stahl R, Duthie F, Krause JH, Bici A, Engelhard CA, Gohlke S, Frommolt P, Gnad T, Rada-Iglesias A, Pradas-Juni M, Schulz TJ, Wunderlich FT, Pfeifer A, Bartelt A, Jastroch M, Wachten D, Kornfeld JW. Khani S, et al. Among authors: larsen bdm. Nat Metab. 2024 Jun;6(6):1053-1075. doi: 10.1038/s42255-024-01033-8. Epub 2024 Apr 29. Nat Metab. 2024. PMID: 38684889

9

Glepaglutide, a novel glucagon-like peptide-2 agonist, has anti-inflammatory and mucosal regenerative effects in an experimental model of inflammatory bowel disease in rats.

Skarbaliene J, Mathiesen JM, Larsen BD, Thorkildsen C, Petersen YM. Skarbaliene J, et al. Among authors: larsen bd. BMC Gastroenterol. 2023 Mar 21;23(1):79. doi: 10.1186/s12876-023-02716-4. BMC Gastroenterol. 2023. PMID: 36944922 Free PMC article.

10

Cancer cells use self-inflicted DNA breaks to evade growth limits imposed by genotoxic stress.

Larsen BD, Benada J, Yung PYK, Bell RAV, Pappas G, Urban V, Ahlskog JK, Kuo TT, Janscak P, Megeney LA, Elsässer SJ, Bartek J, Sørensen CS. Larsen BD, et al. Science. 2022 Apr 29;376(6592):476-483. doi: 10.1126/science.abi6378. Epub 2022 Apr 28. Science. 2022. PMID: 35482866

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters